BARCLAYS PLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,435
-26.5%
166,507
+5.1%
0.00%
-33.3%
Q2 2023$4,676
-69.1%
158,462
-75.9%
0.00%
-57.1%
Q1 2023$15,124
-7.2%
656,427
+12.0%
0.01%0.0%
Q4 2022$16,296
-99.8%
585,965
+80.0%
0.01%
-36.4%
Q3 2022$9,988,000
-8.0%
325,467
-11.7%
0.01%
+57.1%
Q2 2022$10,854,000
+480.4%
368,771
+534.4%
0.01%
+600.0%
Q1 2022$1,870,000
-82.6%
58,132
-75.9%
0.00%
-50.0%
Q4 2021$10,776,000
+201.0%
241,642
+240.5%
0.00%0.0%
Q3 2021$3,580,000
+92.0%
70,965
+198.7%
0.00%
+100.0%
Q2 2021$1,865,000
-63.6%
23,761
-73.5%
0.00%
-66.7%
Q1 2021$5,125,000
+172.3%
89,773
+299.7%
0.00%
+200.0%
Q4 2020$1,882,000
+82.2%
22,458
-22.1%
0.00%0.0%
Q3 2020$1,033,000
+20.1%
28,814
-19.0%
0.00%0.0%
Q2 2020$860,000
+173.9%
35,589
+98.0%
0.00%
Q1 2020$314,000
-63.0%
17,970
-63.1%
0.00%
Q4 2019$848,000
+24.5%
48,668
+9.5%
0.00%
Q3 2019$681,000
+6.1%
44,450
+43.8%
0.00%
Q2 2019$642,000
+101.3%
30,912
+125.2%
0.00%
Q1 2019$319,000
-14.0%
13,728
-19.6%
0.00%
Q3 2018$371,000
+1852.6%
17,071
+1278.9%
0.00%
Q2 2018$19,000
-70.8%
1,238
-62.9%
0.00%
Q1 2018$65,0003,3370.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders